SIBOLD WILLIAM JOHN (President and CEO) sold 1.0% of their position (1.66K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $718.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001628280-26-015769
DirectorOfficer· President and CEO
Since Mar 2026
+32.08K
Net shares
Net buyer
$718.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
33.74K acquired · 1.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.99K
Price / share
—
Trade value
—
% of position
10.1%
3/4/2026
148.50K→163.49K
Common Stock
Direct
Shares
−1.66K
Price / share
$431.94
Trade value
$718.32K
% of position
1.0%
3/6/2026
163.49K→161.83K
Total
Net shares
+13.33K
Net value
-$718.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | A · Award | +14.99K | — | — | 10.1% | 148.50K | 163.49K |
| Common Stock Direct | 3/6/2026 | S · Sale | −1.66K | $431.94 | $718.32K | 1.0% | 163.49K | 161.83K |
| Total | +13.33K | -$718.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
18.74K shares
Shares
+18.74K
Strike price
434.80
Held after
18.74K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18.74K shares | 3/4/2026 | A · Award | +18.74K | 434.80 | — | 18.74K |